Patrick James Orme

Array ( [id] => 7398981 [patent_doc_number] => 20040023266 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-02-05 [patent_title] => 'Methods and compositions for aptamers against anthrax' [patent_app_type] => new [patent_app_number] => 10/387314 [patent_app_country] => US [patent_app_date] => 2003-03-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 24898 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 77 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0023/20040023266.pdf [firstpage_image] =>[orig_patent_app_number] => 10387314 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7361712 [patent_doc_number] => 20040091457 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-05-13 [patent_title] => 'Compositions and methods for inhibiting viral replication' [patent_app_type] => new [patent_app_number] => 10/384512 [patent_app_country] => US [patent_app_date] => 2003-03-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 11642 [patent_no_of_claims] => 73 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 60 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0091/20040091457.pdf [firstpage_image] =>[orig_patent_app_number] => 10384512 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7224727 [patent_doc_number] => 20040072779 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-04-15 [patent_title] => 'Method and medicament for inhibiting the expression of a given gene' [patent_app_type] => new [patent_app_number] => 10/382395 [patent_app_country] => US [patent_app_date] => 2003-03-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 6125 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 57 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0072/20040072779.pdf [firstpage_image] =>[orig_patent_app_number] => 10382395 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6874867 [patent_doc_number] => 20030195164 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-10-16 [patent_title] => 'Novel ribozyme and its use' [patent_app_type] => new [patent_app_number] => 10/372232 [patent_app_country] => US [patent_app_date] => 2003-02-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 11720 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0195/20030195164.pdf [firstpage_image] =>[orig_patent_app_number] => 10372232 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7343319 [patent_doc_number] => 20040191773 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-09-30 [patent_title] => 'Oligoribonucleotides and ribonucleases for cleaving RNA' [patent_app_type] => new [patent_app_number] => 10/371526 [patent_app_country] => US [patent_app_date] => 2003-02-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 32540 [patent_no_of_claims] => 93 [patent_no_of_ind_claims] => 22 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0191/20040191773.pdf [firstpage_image] =>[orig_patent_app_number] => 10371526 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7397221 [patent_doc_number] => 20040038879 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-02-26 [patent_title] => 'Regulation of human p2y1-like g protein-coupled receptor' [patent_app_type] => new [patent_app_number] => 10/344728 [patent_app_country] => US [patent_app_date] => 2003-02-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 27780 [patent_no_of_claims] => 66 [patent_no_of_ind_claims] => 17 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0038/20040038879.pdf [firstpage_image] =>[orig_patent_app_number] => 10344728 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6696336 [patent_doc_number] => 20030108530 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-06-12 [patent_title] => 'Antisense inhibiting melanoma invasion and functional analogs thereof' [patent_app_type] => new [patent_app_number] => 10/247800 [patent_app_country] => US [patent_app_date] => 2003-02-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 6047 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0108/20030108530.pdf [firstpage_image] =>[orig_patent_app_number] => 10247800 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 571282 [patent_doc_number] => 07462703 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-12-09 [patent_title] => 'Agent for gene transfer' [patent_app_type] => utility [patent_app_number] => 10/355933 [patent_app_country] => US [patent_app_date] => 2003-01-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 4894 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 95 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/462/07462703.pdf [firstpage_image] =>[orig_patent_app_number] => 10355933 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6731050 [patent_doc_number] => 20030187240 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-10-02 [patent_title] => '2\' -modified oligonucleotides' [patent_app_type] => new [patent_app_number] => 10/352586 [patent_app_country] => US [patent_app_date] => 2003-01-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 31538 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 82 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0187/20030187240.pdf [firstpage_image] =>[orig_patent_app_number] => 10352586 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6664030 [patent_doc_number] => 20030203356 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-10-30 [patent_title] => 'RNase L activator-antisense complexes' [patent_app_type] => new [patent_app_number] => 10/349163 [patent_app_country] => US [patent_app_date] => 2003-01-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 8590 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0203/20030203356.pdf [firstpage_image] =>[orig_patent_app_number] => 10349163 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7393123 [patent_doc_number] => 20040038246 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-02-26 [patent_title] => 'PIM-3 kinase as a target for type 2 diabetes mellitus' [patent_app_type] => new [patent_app_number] => 10/348081 [patent_app_country] => US [patent_app_date] => 2003-01-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8581 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0038/20040038246.pdf [firstpage_image] =>[orig_patent_app_number] => 10348081 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7322534 [patent_doc_number] => 20040137064 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-07-15 [patent_title] => 'Compositions and processes using siRNA, amphipathic compounds and polycations' [patent_app_type] => new [patent_app_number] => 10/345021 [patent_app_country] => US [patent_app_date] => 2003-01-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 13146 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0137/20040137064.pdf [firstpage_image] =>[orig_patent_app_number] => 10345021 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7136050 [patent_doc_number] => 20040043950 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-03-04 [patent_title] => 'WT1 antisense oligos for the inhibition of breast cancer' [patent_app_type] => new [patent_app_number] => 10/336253 [patent_app_country] => US [patent_app_date] => 2003-01-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 31611 [patent_no_of_claims] => 53 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 36 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0043/20040043950.pdf [firstpage_image] =>[orig_patent_app_number] => 10336253 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6706341 [patent_doc_number] => 20030153075 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-08-14 [patent_title] => 'TGF-beta-specific covalently closed antisense molecule' [patent_app_type] => new [patent_app_number] => 10/334411 [patent_app_country] => US [patent_app_date] => 2002-12-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 10290 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0153/20030153075.pdf [firstpage_image] =>[orig_patent_app_number] => 10334411 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6797097 [patent_doc_number] => 20030175971 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-09-18 [patent_title] => 'Differentiation and/or proliferation modulating agents and uses therefor' [patent_app_type] => new [patent_app_number] => 10/331695 [patent_app_country] => US [patent_app_date] => 2002-12-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 28819 [patent_no_of_claims] => 43 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0175/20030175971.pdf [firstpage_image] =>[orig_patent_app_number] => 10331695 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7304098 [patent_doc_number] => 20040115641 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-06-17 [patent_title] => 'Modulation of ROCK 1 expression' [patent_app_type] => new [patent_app_number] => 10/317883 [patent_app_country] => US [patent_app_date] => 2002-12-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20247 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 41 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0115/20040115641.pdf [firstpage_image] =>[orig_patent_app_number] => 10317883 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7304033 [patent_doc_number] => 20040115633 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-06-17 [patent_title] => 'Modulation of mitochondrial ribosome protein S16 expression' [patent_app_type] => new [patent_app_number] => 10/317248 [patent_app_country] => US [patent_app_date] => 2002-12-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20101 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 43 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0115/20040115633.pdf [firstpage_image] =>[orig_patent_app_number] => 10317248 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7470021 [patent_doc_number] => 20040121323 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-06-24 [patent_title] => 'Mrna binding motif' [patent_app_type] => new [patent_app_number] => 10/168781 [patent_app_country] => US [patent_app_date] => 2002-12-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 25 [patent_no_of_words] => 17475 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0121/20040121323.pdf [firstpage_image] =>[orig_patent_app_number] => 10168781 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7288623 [patent_doc_number] => 20040109848 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-06-10 [patent_title] => 'Modulation of AP-2 alpha expression' [patent_app_type] => new [patent_app_number] => 10/315962 [patent_app_country] => US [patent_app_date] => 2002-12-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 22074 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 42 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0109/20040109848.pdf [firstpage_image] =>[orig_patent_app_number] => 10315962 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7289148 [patent_doc_number] => 20040110142 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-06-10 [patent_title] => 'Modulation of AAC-11 expression' [patent_app_type] => new [patent_app_number] => 10/316230 [patent_app_country] => US [patent_app_date] => 2002-12-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19239 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 41 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0110/20040110142.pdf [firstpage_image] =>[orig_patent_app_number] => 10316230 [rel_patent_id] =>[rel_patent_doc_number] =>)